J. Goldman & Co LP - ACER THERAPEUTICS INC ownership

ACER THERAPEUTICS INC's ticker is ACER and the CUSIP is 00444P108. A total of 41 filers reported holding ACER THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
J. Goldman & Co LP ownership history of ACER THERAPEUTICS INC
ValueSharesWeighting
Q4 2020$943,000
+219.7%
360,000
+389.7%
0.05%
+128.6%
Q4 2019$295,000
-39.4%
73,510
-51.9%
0.02%
-43.2%
Q3 2019$487,000
+24.9%
152,800
+52.8%
0.04%
+37.0%
Q2 2019$390,000
-55.6%
100,001
+145.8%
0.03%
-40.0%
Q2 2018$879,000
-49.4%
40,684
-54.9%
0.04%
-39.2%
Q1 2018$1,738,000
+16.2%
90,202
-16.5%
0.07%
-6.3%
Q4 2017$1,496,000108,0000.08%
Other shareholders
ACER THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
Nantahala Capital Management 1,136,416$1,049,3670.10%
Anson Funds Management LP 129,795$119,8530.02%
HUNTER ASSOCIATES INVESTMENT MANAGEMENT LLC 60,000$550.01%
Hudson Bay Capital Management LP 274,300$253,2890.00%
UBS Group AG 33$300.00%
RHUMBLINE ADVISERS 347$3200.00%
OSAIC HOLDINGS, INC. 200$1840.00%
WELLS FARGO & COMPANY/MN 132$1220.00%
NORTHERN TRUST CORP 22,231$20,5280.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of ACER THERAPEUTICS INC shareholders